Several phosphorylation sites have been identified in PTEN that lead to a loss of phosphatase activity or a gain of stability, such as Ser380, Thr382, and Thr383 [27, 28], which ultimately may result in loss of tumor suppressor function and increased cancer susceptibility. The gene discussed is PTEN; the disease is neoplasm.